Levodopa and the progression of parkinson’s disease

S. Fahn, D. Oakes, I. Shoulson, K. Kieburtz, A. Rudolph, K. Marek, J. Seibyl, A. Lang, C. W. Olanow, C. Tanner, G. Schifitto, H. Zhao, L. Reyes, A. Shinaman, C. Comella, C. Goetz, L. Blasucci, J. Samanta, M. Stacy, K. WilliamsonM. Harrigan, P. Greene, B. Ford, C. Moskowitz, D. Truong, M. Pathak, J. Jankovic, W. Ondo, F. Atassi, C. Hunter, C. Jacques, J. H. Friedman, M. Lannon, D. S. Russell, D. Jennings, B. Fussell, D. Standaert, M. A. Schwarzschild, J. Growdon, M. Tennis, S. Gauthier, M. Panisset, J. Hall, S. Gancher, J. Hammerstad, C. Stone, B. Alexander-Brown, S. Factor, E. Molho, D. Rottenberg, The parkinson study group

Research output: Contribution to journalArticlepeer-review

1549 Scopus citations

Fingerprint

Dive into the research topics of 'Levodopa and the progression of parkinson’s disease'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience